A publication titled "FDA-Approved Drugs Containing D-Amino Acids: A Historical and Developmental Perspective" was published in Drug Development Research on May 1, 2026.
The article is listed under PubMed ID 42041173. It is described as a historical and developmental perspective on FDA-approved drugs that contain D-amino acids.
PT-141, also known as bremelanotide, is referenced in connection with this broader class of compounds discussed in the publication. PT-141 currently holds unapproved research status. No specific findings, data, or conclusions from the publication were provided beyond its title, journal, and publication date.
This brief reports only that the publication exists and has been indexed, without summarizing its content or implications. Readers interested in the compound overview can find additional context there.